Article Information
PubMed
Published By
History
- Received May 29, 2020
- Accepted November 16, 2020
- Published online January 12, 2021.
Copyright & Usage
© Crown copyright 2021. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Erica Ollmann Saphire, Invited Editor, La Jolla Institute for Immunology and The Scripps Research Institute
- Michael S. Diamond, Editor, Washington University School of Medicine
Author Information
- Logan Banadygaa,
- Wenjun Zhua,
- Shweta Kailasanb,
- Katie A. Howellb,
- Krzysztof Franaszekb,
- Shihua Hea,
- Vinayakumar Siragama,
- Keding Chengc,
- Feihu Yana,d,
- Estella Moffate,
- Wenguang Caoa,
- Anders Leunga,
- Carissa Embury-Hyatte,
- M. Javad Amanb,
- Xiangguo Qiua
- aSpecial Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- bIntegrated BioTherapeutics, Inc., Rockville, Maryland, USA
- cScience and Technology Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada
- dKey Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China
- eCanadian Food Inspection Agency, National Centre for Foreign and Animal Disease, Winnipeg, Canada
- Address correspondence to Logan Banadyga, logan.banadyga{at}canada.ca, M. Javad Aman, jaman{at}integratedbiotherapeutics.com, or Xiangguo Qiu, xiangguo.qiu{at}canada.ca.
Citation Banadyga L, Zhu W, Kailasan S, Howell KA, Franaszek K, He S, Siragam V, Cheng K, Yan F, Moffat E, Cao W, Leung A, Embury-Hyatt C, Aman MJ, Qiu X. 2021. Atypical Ebola virus disease in a nonhuman primate following monoclonal antibody treatment is associated with glycoprotein mutations within the fusion loop. mBio 12:e01438-20. https://doi.org/10.1128/mBio.01438-20.